Literature DB >> 323420

Alterations in forebrain catecholamine metabolism produced by cerebellar lesions in the rat.

S R Snider, R S Snider.   

Abstract

Projections from the midline cerebellar nuclei to norepinephrine (NE) and dopamine (DA) cell groups in the brain stem have been demonstrated histologically. To determine if these connections are significant biochemically, unilateral electrolytic lesions were placed in either vermis or paravermis and levels of DA, NE and gamma-aminobutyric acid (GABA) were measured in each half of the forebrain at 1 1/2, 3 or 6 weeks. In the cerebral hemisphere ipsilateral to a vermis lesion, there was a decrease in NE levels at 3 and 6 weeks. Relative to the opposite side DA was also reduced at 3 and 6 weeks. Paravermal lesions caused a contralateral reduction in DA at 3 weeks but no change in NE. GABA was only slightly altered. These results suggest that the cerebellum can modify levels and turnover of catecholamines in the brain, possibly via direct anatomic connections as well as by functional interaction with catecholaminergic pathways.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 323420     DOI: 10.1007/bf01250563

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  36 in total

1.  A cerebellar-ceruleus pathway.

Authors:  R S Snider
Journal:  Brain Res       Date:  1975-04-25       Impact factor: 3.252

2.  Elevations in cerebrospinal fluid norepinephrine during unilateral and bilateral cerebellar stimulation in man.

Authors:  J H Wood; M G Ziegler; C R Lake; J Sode; B R Brooks; J M Van Buren
Journal:  Neurosurgery       Date:  1977 Nov-Dec       Impact factor: 4.654

3.  Anatomic connections of the fastigial nucleus to the rostral forebrain in the cat.

Authors:  J W Harper; R G Heath
Journal:  Exp Neurol       Date:  1973 Mar-Apr       Impact factor: 5.330

4.  Involuntary movements other than Parkinsonism: biochemical aspects.

Authors:  G Curzon
Journal:  Proc R Soc Med       Date:  1973-09

5.  Nucleus fastigii influences on blood flow and blood pressure.

Authors:  J Mitra; R S Snider
Journal:  Int J Neurosci       Date:  1972-06       Impact factor: 2.292

6.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

7.  Effect of dentate stimulation on neuronal activity in the caudate nucleus.

Authors:  R A Ratcheson; C L Li
Journal:  Exp Neurol       Date:  1969-10       Impact factor: 5.330

8.  Synaptic action of the fastigiobulbar impulses upon neurones in the medullary reticular formation and vestibular nuclei.

Authors:  M Ito; M Udo; N Mano; N Kawai
Journal:  Exp Brain Res       Date:  1970       Impact factor: 1.972

9.  Chronic cerebellar stimulation in epilepsy. Clinical and anatomical studies.

Authors:  I S Cooper; I Amin; M Riklan; J M Waltz; T P Poon
Journal:  Arch Neurol       Date:  1976-08

10.  Regional distribution of gamma-aminobutyric acid (GABA) in brain of the rhesus monkey.

Authors:  S Fahn; L J Côté
Journal:  J Neurochem       Date:  1968-03       Impact factor: 5.372

View more
  3 in total

1.  Noradrenergic control of neuronal firing in cerebellar nuclei: modulation of GABA responses.

Authors:  Michela Di Mauro; Guido Li Volsi; Flora Licata
Journal:  Cerebellum       Date:  2013-06       Impact factor: 3.847

2.  Predictive Motor Timing and the Cerebellar Vermis in Schizophrenia: An fMRI Study.

Authors:  Jan Lošák; Jitka Hüttlová; Petra Lipová; Radek Marecek; Martin Bareš; Pavel Filip; Jozef Žubor; Libor Ustohal; Jirí Vanícek; Tomáš Kašpárek
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

3.  Epigenetic Regulation of Neural Transmission after Cerebellar Fastigial Nucleus Lesions in Juvenile Rats.

Authors:  Simeon O A Helgers; Svilen Angelov; Marc A N Muschler; Alexander Glahn; Shadi Al-Afif; Yazeed Al Krinawe; Elvis J Hermann; Joachim K Krauss; Helge Frieling; Kerstin Schwabe; Mathias Rhein
Journal:  Cerebellum       Date:  2021-04-08       Impact factor: 3.847

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.